Fjorda Koromani

Fjorda Koromani is a Researcher in the Internal Medicine department at Erasmus MC, University Medical Center Rotterdam. Her work focuses on bone health research with particular emphasis on fracture risk assessment and prevention strategies.

Dr. Koromani's research interests span multiple areas of bone health including osteoporosis, fracture risk assessment (particularly using FRAX), rheumatoid arthritis complications, and the relationship between diabetes and bone fragility. Her work often involves large-scale meta-analyses and utilizes genetic approaches such as Mendelian randomization to establish causal relationships.

Her recent publications demonstrate a strong focus on international comparisons of fracture prevention strategies, the intersection of inflammatory conditions with bone health, and methodological approaches to assessing fracture risk. She frequently collaborates with international research groups and contributes to clinical guidelines in the field of bone health.

Dr. Koromani has been involved in several high-impact studies that have been referenced in clinical guidelines and picked up by multiple news outlets, indicating the significance and applicability of her research to clinical practice.